vancomycin has been researched along with Liver Diseases in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 5 (29.41) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Brunetti, L; Kim, HJ; Lee, DS; Lee, SM; Seong, YH; Song, JH; Suh, D; Suh, DC | 1 |
Hadzic, N; Hierro, L | 1 |
Chang, CH; Chang, SC; Chen, SC; Chen, SY; Chen, WJ; Chiang, WC; Chie, WC; Hsueh, PR; Huang, EP; Lai, MS; Lin, CF | 1 |
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
Banach, DB; Dembry, LM; Emre, S; Fortune, BE; Peaper, DR | 1 |
BARBER, M | 1 |
D'Alessandro, A; Kalayoglu, M; Knechtle, SJ; Lucey, MR; Maki, DG; Musat, A; Pirsch, J; Safdar, N; Said, A | 1 |
Alves, EM; Castelo Branco, R; de Gouvea, EF; Ferreira, AL; Halpern, M; Monteiro, RC; Moreira, BM; Ribeiro-Filho, J; Santoro-Lopes, G | 1 |
Bodey, GP; Bogerd, L; Bolivar, R; Brown, N; Fainstein, V; Fong, KL; Ho, DH; Maksymiuk, A | 1 |
Baillie, LW; Casewell, MW; Wade, JJ | 1 |
Fung, JJ; Kramer, DJ; Kusne, S; Linden, PK; Manez, R; Pasculle, AW; Pinna, AD | 1 |
Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
DeFranco, PE; Goebel, J; Lee, B; Shook, LA | 1 |
Hirono, S; Kobayashi, H; Orii, T; Tanaka, M | 1 |
Courtois, P; de Lemos, E; Fauconneau, B; Pariat, C; Piriou, A | 1 |
Pachorek, RE; Wood, F | 1 |
Imai, F; Kameda, H | 1 |
1 review(s) available for vancomycin and Liver Diseases
Article | Year |
---|---|
Autoimmune liver disease: novelties in management.
Topics: Anti-Bacterial Agents; Antibodies; Autoimmune Diseases; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Diseases; Vancomycin | 2014 |
1 trial(s) available for vancomycin and Liver Diseases
Article | Year |
---|---|
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Liver Diseases; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Vancomycin | 1996 |
15 other study(ies) available for vancomycin and Liver Diseases
Article | Year |
---|---|
The risk of vancomycin toxicity in patients with liver impairment.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Liver Diseases; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Serum; Staphylococcal Infections; Vancomycin; Young Adult | 2020 |
Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chronic Disease; Community-Acquired Infections; Decision Support Techniques; Female; Hospitalization; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Respiratory Tract Infections; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
Topics: Anti-Bacterial Agents; Connecticut; Enterococcus; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2016 |
TOXICITY OF ANTIBIOTICS OTHER THAN PENICILLIN.
Topics: Anti-Bacterial Agents; Bacitracin; Bone Marrow Diseases; Drug Eruptions; Gastrointestinal Diseases; Kanamycin; Kidney Diseases; Liver Diseases; Necrosis; Neomycin; Neurologic Manifestations; Penicillins; Pharmacology; Polymyxins; Ristocetin; Streptomycin; Tetracycline; Toxicology; Vancomycin; Vestibule, Labyrinth | 1965 |
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention.
Topics: Candidiasis; Case-Control Studies; Cohort Studies; Constriction, Pathologic; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Staphylococcal Infections; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2004 |
Surveillance for vancomycin-resistant enterococci colonization among patients of a liver transplant program.
Topics: Adult; Enterococcus; Female; Fibrosis; Gram-Positive Bacterial Infections; Humans; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Risk Factors; Vancomycin | 2005 |
Effects of hepatic function on vancomycin clinical pharmacology.
Topics: Adult; Aged; Animals; Creatinine; Female; Humans; Kidney; Kinetics; Liver; Liver Diseases; Middle Aged; Rabbits; Vancomycin | 1983 |
Colonial variation in vancomycin resistant Enterococcus faecium.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Humans; Liver Diseases; Microbial Sensitivity Tests; Vancomycin | 1993 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |
Solitary hepatic abscess with associated glomerulonephritis in a neonate.
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Drainage; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Infant, Newborn; Liver Diseases; Magnetic Resonance Imaging; Micrococcus; Staphylococcal Infections; Vancomycin | 2000 |
[Examination of factors affecting efficacy and adverse effect, for the retrospective study of vancomycin hydrochloride (VCM)].
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Kidney Diseases; Liver Diseases; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Therapeutic Equivalency; Treatment Outcome; Vancomycin | 2001 |
[Circadian variations in the nephrotoxicity of the vancomycin-gentamicin combination in rats].
Topics: Acetylglucosaminidase; Aminopeptidases; Animals; CD13 Antigens; Chemical and Drug Induced Liver Injury; Circadian Rhythm; Creatine; Drug Therapy, Combination; Gentamicins; Liver Diseases; Male; Rats; Rats, Inbred Strains; Vancomycin | 1991 |
Vancomycin half-life in a patient with hepatic and renal dysfunction.
Topics: Aged; Half-Life; Humans; Kidney Diseases; Liver Diseases; Male; Metabolic Clearance Rate; Vancomycin | 1991 |
[Liver diseases and colonic dysfunction].
Topics: Colon; Colonic Diseases; Female; Humans; Lactulose; Liver Circulation; Liver Diseases; Middle Aged; Regional Blood Flow; Vancomycin | 1988 |